# iBody

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ibody

- Industry: Biotechnology
- Headquarters: Nagoya, Japan
- Website: www.ibody.co.jp
- Total disclosed funding: $0.9M
- Latest round: Series A (May 16, 2018)
- Investors on record: 1

## About

Established in 2018, and based in Aichi, Japan, iBody Inc. engages in the research and development of human monoclonal antibodies, as well as the screening of human and rabbit monoclonal antibodies. iBody’s unique Ecobody technology enables lightning-fast antibody expression and evaluation.

## Funding rounds

- Series A, May 16, 2018, $0.9M — Nissay Capital

## Investors

- Nissay Capital (https://capitalatlas.ai/funds/nissay-capital) — Series A